论文部分内容阅读
本文报告中山医学院附属肿瘤医院头颈科和附属第一医院肿瘤科自1958～1972年共14年间治疗的舌癌241例的远期疗效。全组病例均获随访,随诊率100％,平均五年生存率为53.9(130/241)。其中,计划综合治疗组(即原发灶外照射+镭针插植术,并加颈淋巴结清除术)五年生存率为68.3％(28/41);联合根治术组五年生存率为59.3％(70/118);镭针插植术组五年生存率为39.1％(32/82)。全组共有159例行颈淋巴结清除术,术后病理检查有淋巴结转移的51例(颈淋巴结转移率为32.1％)。
This paper reports the long-term efficacy of 241 cases of tongue cancer treated in the Department of Head and Neck Surgery of the Affiliated Tumor Hospital of Zhongshan Medical College and First Affiliated First Hospital from 1958 to 1972 for 14 years. All patients were followed up, the follow-up rate was 100%, and the average five-year survival rate was 53.9 (130/241). Among them, the planned five-year survival rate was 68.3% (28/41) in the combined treatment group (external irradiation + radium needle implantation and neck lymph node dissection); the five-year survival rate was 59.3 in the combined radical surgery group. % (70/118); The five-year survival rate of the thoracic needle implantation group was 39.1% (32/82). A total of 159 patients underwent cervical lymph node dissection. Postoperative pathological examination revealed lymph node metastasis in 51 patients (32.1% of cervical lymph node metastases).